4DMedicalASX:4DX -8.97%64 OCF Margin % is -451.86% as of Dec. 2025. GuruFocus rates ASX:4DX with a GF Score™ of 64/100 and a GF Value™ of A$1.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, 4DMedical ranks worse than 92.76% on this metric.
The historical rank and industry rank for 4DMedical's OCF Margin % or its related term are showing as below:
ASX:4DX'
s OCF Margin % Range Over the Past 10 Years
Min: -8032.98 Med: -1704.74 Max: -596.66
Current: -580.25
During the past 6 years, the highest OCF Margin % of 4DMedical was -596.66%. The lowest was -8032.98%. And the median was -1704.74%.
ASX:4DX's OCF Margin % is ranked worse than 92.76% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs ASX:4DX: -580.25
4DMedical OCF Margin % Related Terms
4DMedical OCF Margin % Historical Data
* Premium members only.
The historical data trend for 4DMedical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 4DMedical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where 4DMedical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (ASX:4DX) has a OCF Margin % of -451.86% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #756 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 92.8%.
Is 4DMedical's OCF Margin % too high?
4DMedical's current OCF Margin % is -451.86%. Based on the distribution chart, 4DMedical ranks #756 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 4DMedical has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #756 out of 815 companies for OCF Margin %. This places 4DMedical in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current OCF Margin % is -451.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$1.44, compared to a current price of A$4.16 — trading 188.9% above its estimated fair value. The current OCF Margin % is -451.86%. 4DMedical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current OCF Margin % is -451.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (ASX:4DX) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of A$4.16 is trading 188.9% above its estimated GF Value™ of A$1.44.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for ASX:4DX:
OCF Margin %: -451.86%
GF Value™: A$1.44 vs. price of A$4.16 (188.9% above fair value)
No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
64GF Score
Get the complete analysis for ASX:4DX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:4DX has been successfully added to your 
